Advertisement
Advertisement

FLGT

FLGT logo

Fulgent Genetics Inc

18.35
USD
-0.4
-2.13%
Dec 20, 15:59 UTC -5
Closed
...

Fulgent Genetics Inc Profile

About

Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.

Info & Links

CEO

Ming Hsieh

Headquarters

4399 SANTA ANITA AVENUE
EL MONTE, CA 91731, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

14

Employees

1,184

Fulgent Genetics Inc Statistics

Valuation Measures

Market Capitalization2

561.33M

Enterprise Value

503.70M

Enterprise Value/EBITDA(ttm)

-7.31

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.06

Price to Book(mrq)

0.50

Price to Cash(ytd)

5.77

Profitability

Gross Margin(ttm)

36.17%

Operating Margin(ttm)

-7.39%

Profit Margin(ttm)

-58.83%

Return on Equity(ttm)

-1.81%

Return on Invested Capital(ttm)

-15.18%

Return on Assets(ttm)

-1.66%

Income Statement

Revenue(ttm)

277.76M

Revenue Per Share(ttm)

9.08

Gross Profit(ttm)

100.59M

EBITDA(ttm)3

-68.94M

Net Income Available to Common(ttm)

-164.97M

Diluted EPS(ttm)

-5.52

Share Statistics

Beta (5Y Monthly)

1.42

52-Week Change

-33.20%

S&P 500 52-Week Change

24.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

30.59M

Dividend Yield

0.00%

Float4

20.87M

% Held by Insiders

31.76%

% Held by Institutions

48.06%

Balance Sheet

Total Cash(mrq)

213.07M

Total Cash Per Share(mrq)

6.97

Total Debt(mrq)

412.00K

Total Debt/Equity(mrq)

0.04%

Current Ratio(mrq)

4.41%

Quick Ratio(mrq)

4.41%

Book Value Per Share(mrq)

37.16

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.13

Free Cash Flow(ytd)

-40.18M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement